Mock-up Updates Study Tags (field_study_tags) - Any - ADEQUATE Blog Call-outs CLIN-Net CoMeCT COVID-19 Data Ecraid ECRAID-Base EPI-Net EPOXI Mpox NeoDeco Partners People PIPELINE POS-ARI-ER POS-ARI-PC POS-cUTI POS-Disease X POS-VAP Primary Care PRUDENCE RECLAIM RECOVERY REMAP-CAP SNAP SOS Covid Training 5.03.2024 Young Investigator Workshop returns to ECCMID in 2024 Young investigators working on Ecraid studies will share valuable advice and lessons learned. 29.02.2024 Ecraid network responds to hypervirulent Klebsiella pneumoniae warning The POS-cUTI and POS-VAP study teams swiftly analysed their data to quantify the prevalence of the dangerous bacterium. 28.02.2024 Maximising the utility of connected data in ECRAID-Base, Part 1: Data management In the first interview of our two-part series, we talk with Frank Leus about his team's role in the project. 27.02.2024 Free webinar on complicated urinary tract infections Experts will explore changing definitions, microbiological challenges and novel trial designs on 10 April 2024. 14.02.2024 New trial tests potential treatments for Long COVID The RECLAIM adaptive platform trial will soon begin enrolling patients in the Netherlands. 22.01.2024 CoMeCT: Advancing trial and cohort study harmonisation Ecraid joins CoMeCT to promote a coordinated and collaborative approach to infectious disease clinical research. Load More
5.03.2024 Young Investigator Workshop returns to ECCMID in 2024 Young investigators working on Ecraid studies will share valuable advice and lessons learned.
29.02.2024 Ecraid network responds to hypervirulent Klebsiella pneumoniae warning The POS-cUTI and POS-VAP study teams swiftly analysed their data to quantify the prevalence of the dangerous bacterium.
28.02.2024 Maximising the utility of connected data in ECRAID-Base, Part 1: Data management In the first interview of our two-part series, we talk with Frank Leus about his team's role in the project.
27.02.2024 Free webinar on complicated urinary tract infections Experts will explore changing definitions, microbiological challenges and novel trial designs on 10 April 2024.
14.02.2024 New trial tests potential treatments for Long COVID The RECLAIM adaptive platform trial will soon begin enrolling patients in the Netherlands.
22.01.2024 CoMeCT: Advancing trial and cohort study harmonisation Ecraid joins CoMeCT to promote a coordinated and collaborative approach to infectious disease clinical research.
